Showing 1 to 3 of 3 results


Mean Reversion: A More Accurate Approach to Retirement Planning
Scott Bondurant of Bondurant Investment Advisory explains mean reversion in financial planning, contrasting it with the random walk theory and highlighting its implications for retirement portfolios, particularly the potential benefits of higher equity allocations despite short-term volatility.
Mean Reversion: A More Accurate Approach to Retirement Planning
Scott Bondurant of Bondurant Investment Advisory explains mean reversion in financial planning, contrasting it with the random walk theory and highlighting its implications for retirement portfolios, particularly the potential benefits of higher equity allocations despite short-term volatility.
Progress
48% Bias Score


AMD Stock Shows Signs of Recovery, Potential Mean-Reverting Rally
AMD stock, after a significant decline, shows signs of recovery as it holds above the $130 support level, suggesting a potential mean-reverting rally towards $170, based on technical analysis and two prior similar rallies totaling +76%.
AMD Stock Shows Signs of Recovery, Potential Mean-Reverting Rally
AMD stock, after a significant decline, shows signs of recovery as it holds above the $130 support level, suggesting a potential mean-reverting rally towards $170, based on technical analysis and two prior similar rallies totaling +76%.
Progress
48% Bias Score

Undervalued Canadian Stocks Show Potential Upside Despite 2024 Declines
This article uses Stockcalc's valuation tools to identify 10 undervalued Canadian stocks from the S&P/TSX Composite Index that are down 20-30% year-to-date, highlighting BCE and Interfor as examples with potential upside despite recent price drops and challenges.

Undervalued Canadian Stocks Show Potential Upside Despite 2024 Declines
This article uses Stockcalc's valuation tools to identify 10 undervalued Canadian stocks from the S&P/TSX Composite Index that are down 20-30% year-to-date, highlighting BCE and Interfor as examples with potential upside despite recent price drops and challenges.
Progress
40% Bias Score
Showing 1 to 3 of 3 results